Biography
Clayton Erwin provides strategic communications advice and support to public and private companies in the U.S. and abroad in a variety of complex special situations.
Navigating the intersection of business, media and the investment community, Clayton has generated and executed on tailored ideas and delivered tangible results. His areas of expertise include friendly and hostile mergers and acquisitions, corporate crises and issues management, and shareholder activism, in addition to ongoing public and investor relations.
Prior to joining Collected, Clayton was a Managing Director at Joele Frank. He received a BA in English, cum laude, from Yale University and an MS in Journalism from the Columbia University Graduate School of Journalism.
M&A
- Beazer Homes (defense against $705M hostile offer from Dream Finders Homes)
- Cross Country Healthcare ($437 million sale to Knox Lane)
- TriPointe Homes ($4.5 billion sale to Sumitomo Forestry)
- American Woodmark ($3.6 billion merger with MasterBrand)
- MRC Global ($1.5 billion merger with DNow)
- Sekisui House ($4.9 billion acquisition of MDC Holdings)
- The Cigna Group ($3.7 billion sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D and CareAlliesbusinesses to Health Care Service Corporation)
- Hudson Valley Credit Union ($28.6 million acquisition of CatskillHudson Bank)
- UpHealth ($180 million sale of Cloudbreak to GTCR)
- Veradigm ($140 million acquisition of ScienceIO)
- Iveric Bio ($5.9billion sale to Astellas Pharma)
- Jack in the Box ($585 million acquisition of Del Taco)
- Matthews in its defense against Barington Capital
- Colgate in its defense against Third Point
- Eagle Materials in its defense against Sachem Head Capital Management
- Elanco in its settlement with Sachem Head Capital Management
- Humana in its settlement with Starboard Value
- Huntsman in its successful proxy contest against Starboard Value
- Perspecta in its defense against JANA
- Progenics in its defense against Velan Capital
- Virtusa in its defense against New Mountain Capital
- Veradigm ($140 million acquisition of ScienceIO)
- Iveric Bio ($5.9 billion sale to Astellas Pharma)
- Jack in the Box ($585 million acquisition of Del Taco)
Our Track Record
Experience that speaks for itself.
Our founding team has advised on over $3.7 trillion in transactions, 400+ activist engagements, and 80+ restructurings. See our full record of selected transactions, league table rankings, and practice area depth.
View Our Experience →$3.7TIn transactions advised
400+Activist engagements
80+Restructurings
#3Bloomberg 2025 activism rankings